Global Small Molecule Active Pharmaceutical Ingredient Market Professional Survey Report 2018

Published Date : 29-Jan-2018

No. of Pages : 123

No. Of Tables and Figure : 141

Contact : sales@qyresearchmedical.com

DESCRIPTION

This report studies Small Molecule Active Pharmaceutical Ingredient in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co, Inc.
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Standard API
High Potency API

By Application, the market can be split into
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.


TABLE OF CONTENT

Table of Contents

Global Small Molecule Active Pharmaceutical Ingredient Market Professional Survey Report 2017
1 Industry Overview of Small Molecule Active Pharmaceutical Ingredient
1.1 Definition and Specifications of Small Molecule Active Pharmaceutical Ingredient
1.1.1 Definition of Small Molecule Active Pharmaceutical Ingredient
1.1.2 Specifications of Small Molecule Active Pharmaceutical Ingredient
1.2 Classification of Small Molecule Active Pharmaceutical Ingredient
1.2.1 Standard API
1.2.2 High Potency API
1.3 Applications of Small Molecule Active Pharmaceutical Ingredient
1.3.1 Cardiovascular Diseases
1.3.2 Respiratory Disorders
1.3.3 Infectious Diseases
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Small Molecule Active Pharmaceutical Ingredient
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Small Molecule Active Pharmaceutical Ingredient
2.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
2.4 Industry Chain Structure of Small Molecule Active Pharmaceutical Ingredient

3 Technical Data and Manufacturing Plants Analysis of Small Molecule Active Pharmaceutical Ingredient
3.1 Capacity and Commercial Production Date of Global Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016

4 Global Small Molecule Active Pharmaceutical Ingredient Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Small Molecule Active Pharmaceutical Ingredient Capacity and Growth Rate Analysis
4.2.2 2016 Small Molecule Active Pharmaceutical Ingredient Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate Analysis
4.3.2 2016 Small Molecule Active Pharmaceutical Ingredient Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Small Molecule Active Pharmaceutical Ingredient Sales Price
4.4.2 2016 Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis (Company Segment)

5 Small Molecule Active Pharmaceutical Ingredient Regional Market Analysis
5.1 North America Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.1.1 North America Small Molecule Active Pharmaceutical Ingredient Market Overview
5.1.2 North America 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.1.4 North America 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
5.2 China Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.2.1 China Small Molecule Active Pharmaceutical Ingredient Market Overview
5.2.2 China 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.2.4 China 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
5.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.3.1 Europe Small Molecule Active Pharmaceutical Ingredient Market Overview
5.3.2 Europe 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.3.4 Europe 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
5.4 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.4.1 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Market Overview
5.4.2 Southeast Asia 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.4.4 Southeast Asia 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
5.5 Japan Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.5.1 Japan Small Molecule Active Pharmaceutical Ingredient Market Overview
5.5.2 Japan 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.5.4 Japan 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
5.6 India Small Molecule Active Pharmaceutical Ingredient Market Analysis
5.6.1 India Small Molecule Active Pharmaceutical Ingredient Market Overview
5.6.2 India 2012-2017E Small Molecule Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales Price Analysis
5.6.4 India 2016 Small Molecule Active Pharmaceutical Ingredient Market Share Analysis

6 Global 2012-2017E Small Molecule Active Pharmaceutical Ingredient Segment Market Analysis (by Type)
6.1 Global 2012-2017E Small Molecule Active Pharmaceutical Ingredient Sales by Type
6.2 Different Types of Small Molecule Active Pharmaceutical Ingredient Product Interview Price Analysis
6.3 Different Types of Small Molecule Active Pharmaceutical Ingredient Product Driving Factors Analysis
6.3.1 Standard API of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.2 High Potency API of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis

7 Global 2012-2017E Small Molecule Active Pharmaceutical Ingredient Segment Market Analysis (by Application)
7.1 Global 2012-2017E Small Molecule Active Pharmaceutical Ingredient Consumption by Application
7.2 Different Application of Small Molecule Active Pharmaceutical Ingredient Product Interview Price Analysis
7.3 Different Application of Small Molecule Active Pharmaceutical Ingredient Product Driving Factors Analysis
7.3.1 Cardiovascular Diseases of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.2 Respiratory Disorders of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.3 Infectious Diseases of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.4 Others of Small Molecule Active Pharmaceutical Ingredient Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Small Molecule Active Pharmaceutical Ingredient
8.1 Johnson Matthey
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Johnson Matthey 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Johnson Matthey 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.2 Siegfried Holding AG
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Siegfried Holding AG 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Siegfried Holding AG 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.3 Pfizer
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Pfizer 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Pfizer 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.4 Sanofi S.A.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Sanofi S.A. 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi S.A. 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.5 Novartis AG,
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Novartis AG, 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Novartis AG, 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Bristol-Myers Squibb 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bristol-Myers Squibb 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.7 Boehringer Ingelheim GmbH
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Boehringer Ingelheim GmbH 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Boehringer Ingelheim GmbH 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.8 GlaxoSmithKline
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 GlaxoSmithKline 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 GlaxoSmithKline 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.9 Albany Molecular Research Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Albany Molecular Research Inc. 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Albany Molecular Research Inc. 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.10 Bachem Holding AG
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Bachem Holding AG 2016 Small Molecule Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Bachem Holding AG 2016 Small Molecule Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.11 PCAS
8.12 Patheon N.V.
8.13 AstraZeneca
8.14 Johnson & Johnson
8.15 Merck & Co, Inc.
8.16 BASF SE
8.17 Catalent Inc.
8.18 Teva Pharmaceuticals
8.19 Roche
8.20 Cambrex Corporation
8.21 GILEAD Science Inc.

9 Development Trend of Analysis of Small Molecule Active Pharmaceutical Ingredient Market
9.1 Global Small Molecule Active Pharmaceutical Ingredient Market Trend Analysis
9.1.1 Global 2017-2022 Small Molecule Active Pharmaceutical Ingredient Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Small Molecule Active Pharmaceutical Ingredient Sales Price Forecast
9.2 Small Molecule Active Pharmaceutical Ingredient Regional Market Trend
9.2.1 North America 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.2.2 China 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.2.3 Europe 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.2.5 Japan 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.2.6 India 2017-2022 Small Molecule Active Pharmaceutical Ingredient Consumption Forecast
9.3 Small Molecule Active Pharmaceutical Ingredient Market Trend (Product Type)
9.4 Small Molecule Active Pharmaceutical Ingredient Market Trend (Application)

10 Small Molecule Active Pharmaceutical Ingredient Marketing Type Analysis
10.1 Small Molecule Active Pharmaceutical Ingredient Regional Marketing Type Analysis
10.2 Small Molecule Active Pharmaceutical Ingredient International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Small Molecule Active Pharmaceutical Ingredient by Region
10.4 Small Molecule Active Pharmaceutical Ingredient Supply Chain Analysis

11 Consumers Analysis of Small Molecule Active Pharmaceutical Ingredient
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Small Molecule Active Pharmaceutical Ingredient Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


Single-user license provides facilities to be used by only one user. Enterprise-user license has been designed for more than one user to access the report at the same or different time.

We Will also support Word, PPT, Excel Files Dispatch
Our Clients